Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021

肺癌手術の世界市場予測(~2021):処方術別(胸腔切開術(肺摘除術、肺切除術、セグメンテーション切除術)、最小侵襲性)、機器別(外科手術(クランプ、鉗子、リトラクタ、ステープラ)、監視方法別(カメラ、トロカール)、内視鏡装置)

◆タイトル:Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021
◆商品コード:MAM-MD-4960
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年1月31日
◆ページ数:138
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、肺癌手術の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、処方術別分析、機器別分析、地域別分析、肺癌手術の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The lung cancer surgery market is projected to reach USD 29.99 billion by 2021 from USD 21.58 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. The global lung cancer surgery market is segmented based on device, procedure, and region. On the basis of device, the lung cancer surgery market is segmented into surgical instruments, monitoring and visualizing systems, and endosurgical equipment. The monitoring and visualizing systems segment is expected to register the highest CAGR during the forecast period. Increasing awareness about advanced treatment procedures such as video-assisted thoracoscopic surgeries (VATS) and laser surgeries are the factors driving the growth of this segment.
On the basis of procedure, the lung cancer surgery market is classified into thoracotomy and minimally invasive surgeries. The thoracotomy segment further sub segmented into lobectomy, sleeve resection, segmentectomy, and pneumonectomy. In 2016, the thoracotomy segment is expected to account for the largest share of the global lung cancer surgery. These surgeries are widely adopted to confirm the diagnosis of lung cancer, remove tumours and scar tissue, or fix air leaks. Moreover, availability of skilled professional for performing thoracotomy and less time for surgery are the major factors that will drive the growth of this segment.

Geographically, North America dominates the global lung cancer surgery market. Growth in the North American segment is primarily driven by the rapid growth in the aging population, availability of reimbursement for lung cancer surgeries, and increasing incidence of lung cancer.
The major factors contributing to the growth of the global lung cancer surgery market include the increasing incidence and prevalence of cancer, increasing lung cancer awareness campaigns, and rising aging population. On the other hand, high cost of lung cancer surgery is restraining the growth of this market. The high growth potential in the Asian region provides opportunities for players in the lung cancer surgery market.

The major players in the lung cancer surgery market are Ethicon US LLC (U.S.), Intuitive Surgical Inc. (U.S.), Olympus Corporation (Japan), Accuray Inc. (U.S.), AngioDynamics Inc. (U.S.), Teleflex Inc. (U.S.), KARL STORZ GmbH (Germany), Ackermann Instrumente GmbH (Germany), Scanlan International Inc. (U.S.), and Trokamed GmbH (Germany).
Research Coverage

Apart from comprehensive geographic and devices analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in the market.

Reasons to Buy the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Companies purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the lung cancer surgery market. The report analyses the lung cancer surgery market by device, procedure, and region.
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the lung cancer surgery market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the lung cancer surgery market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for lung cancer surgery across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the lung cancer surgery market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKETS COVERED 14
1.4 YEARS CONSIDERED FOR THE STUDY 15
1.5 CURRENCY 16
1.6 LIMITATIONS 16
1.7 STAKEHOLDERS 16
2 RESEARCH METHODOLOGY 17
2.1 SECONDARY DATA 18
2.1.1 KEY DATA FROM SECONDARY SOURCES 18
2.2 PRIMARY DATA 19
2.2.1 KEY DATA FROM PRIMARY SOURCES 20
2.3 MARKET SIZE ESTIMATION 20
2.3.1 BOTTOM-UP APPROACH 21
2.3.2 TOP-DOWN APPROACH 22
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 23
2.5 ASSUMPTIONS FOR THE STUDY 24
3 EXECUTIVE SUMMARY 25
3.1 INTRODUCTION 25
3.2 CONCLUSION 29
4 PREMIUM INSIGHTS 30
4.1 LUNG CANCER SURGICAL DEVICES MARKET OVERVIEW 30
4.2 GEOGRAPHIC ANALYSIS: LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE 31
4.3 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE, 2016-2021 32
4.4 LUNG CANCER SURGICAL DEVICES MARKET, BY REGION, 2016-2021 33
5 MARKET OVERVIEW 34
5.1 INTRODUCTION 35
5.2 MARKET DYNAMICS 35
5.2.1 DRIVERS 36
5.2.1.1 Technological advancements in lung cancer treatment 36
5.2.1.2 Increasing incidence and prevalence of lung cancer 36
5.2.1.3 Rising geriatric population 37
5.2.1.4 Increasing number of awareness initiatives aimed at early detection of cancer 37
5.2.2 RESTRAINTS 38
5.2.2.1 High cost of lung cancer surgeries 38
5.2.3 OPPORTUNITIES 38
5.2.3.1 Untapped emerging markets 38
5.2.4 CHALLENGES 39
5.2.4.1 Entry barriers for new players 39
5.2.4.2 Dearth of oncologists 39
6 LUNG CANCER SURGICAL DEVICES MARKET, BY TYPE 40
6.1 INTRODUCTION 41
6.2 SURGICAL INSTRUMENTS 43
6.2.1 HAND INSTRUMENTS 44
6.2.1.1 Staplers 45
6.2.1.2 Forceps 46
6.2.1.3 Retractors 46
6.2.1.4 Rib shears 47
6.2.1.5 Trocars 48
6.2.1.6 Cutters 48
6.2.1.7 Clamps 49
6.2.1.8 Scissors 50
6.2.1.9 Elevators 50
6.2.1.10 Other hand instruments 51
6.3 MONITORING AND VISUALIZING SYSTEMS 52
6.3.1 CAMERAS & VIDEO SUPPORT 53
6.3.2 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS 54
6.3.3 ENDOSURGICAL EQUIPMENT 54
7 LUNG CANCER SURGICAL PROCEDURES MARKET, BY TYPE 56
7.1 INTRODUCTION 57
7.2 THORACOTOMY 59
7.2.1 LOBECTOMY 60
7.2.2 SLEEVE RESECTION 62
7.2.3 SEGMENTECTOMY 62
7.2.4 PNEUMONECTOMY 63
7.3 MINIMALLY INVASIVE SURGERIES 64
8 LUNG CANCER SURGERY MARKET, BY REGION 66
8.1 INTRODUCTION 67
8.2 NORTH AMERICA 70
8.2.1 U.S. 75
8.2.2 CANADA 77

8.3 EUROPE 80
8.4 ASIA 82
8.4.1 CHINA 88
8.4.2 JAPAN 90
8.4.3 INDIA 93
8.4.4 ROA 95
8.5 REST OF THE WORLD (ROW) 98
9 COMPETITIVE LANDSCAPE 101
9.1 INTRODUCTION 101
9.2 STRATEGIC OVERVIEW 101
9.3 MARKET SHARE ANALYSIS 102
9.4 COMPETITIVE SITUATION AND TRENDS 103
9.4.1 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 104
9.4.2 PRODUCT LAUNCHES 105
9.4.3 EXPANSIONS 106
9.4.4 ACQUISITIONS 106
9.4.5 OTHER DEVELOPMENTS 107
10 COMPANY PROFILES 108
(Overview, Products and Services, Financials, Strategy & Development)*
10.1 INTRODUCTION 108
10.2 ACCURAY INCORPORATED 109
10.3 ANGIODYNAMICS INC. 112
10.4 ETHICON US, LLC (JOHNSON & JOHNSON) 114
10.5 INTUITIVE SURGICAL INC. 116
10.6 OLYMPUS CORPORATION 118
10.7 TELEFLEX INCORPORATED 120
10.8 ACKERMANN INSTRUMENTE GMBH 122
10.9 KARL STORZ GMBH 123
10.10 SCANLAN INTERNATIONAL, INC. 125
10.11 TROKAMED GMBH 126
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

11 APPENDIX 127
11.1 INSIGHTS OF INDUSTRY EXPERTS 127
11.2 DISCUSSION GUIDE 128
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 130
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 132
11.5 AVAILABLE CUSTOMIZATIONS 134
11.6 RELATED REPORTS 134
11.7 AUTHOR DETAILS 135

LIST OF TABLES

TABLE 1 LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 42
TABLE 2 SURGICAL INSTRUMENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 43
TABLE 3 SURGICAL INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 43
TABLE 4 HAND INSTRUMENTS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 44
TABLE 5 HAND INSTRUMENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 45
TABLE 6 HAND INSTRUMENTS MARKET SIZE FOR STAPLERS, BY REGION,
2014–2021 (USD MILLION) 45
TABLE 7 HAND INSTRUMENTS MARKET SIZE FOR FORCEPS, BY REGION,
2014–2021 (USD MILLION) 46
TABLE 8 HAND INSTRUMENTS MARKET SIZE FOR RETRACTORS, BY REGION,
2014–2021 (USD MILLION) 47
TABLE 9 HAND INSTRUMENTS MARKET SIZE FOR RIB SHEARS, BY REGION,
2014–2021 (USD MILLION) 47
TABLE 10 HAND INSTRUMENTS MARKET SIZE FOR TROCARS, BY REGION,
2014–2021 (USD MILLION) 48
TABLE 11 HAND INSTRUMENTS MARKET SIZE FOR CUTTERS, BY REGION,
2014–2021 (USD MILLION) 49
TABLE 12 HAND INSTRUMENTS MARKET SIZE FOR CLAMPS, BY REGION,
2014–2021 (USD MILLION) 49
TABLE 13 HAND INSTRUMENTS MARKET SIZE FOR SCISSORS, BY REGION,
2014–2021 (USD MILLION) 50
TABLE 14 HAND INSTRUMENTS MARKET SIZE FOR ELEVATORS, BY REGION,
2014–2021 (USD MILLION) 51
TABLE 15 OTHER HAND INSTRUMENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 51
TABLE 16 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 52
TABLE 17 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 53
TABLE 18 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE FOR CAMERAS & VIDEO SUPPORT, BY REGION, 2014–2021 (USD MILLION) 53
TABLE 19 MONITORING AND VISUALIZING SYSTEMS MARKET SIZE FOR ENDOSCOPIC TROCARS WITH OPTICAL VIEWS, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 20 ENDOSURGICAL EQUIPMENT MARKET SIZE BY REGION,
2014–2021 (USD MILLION) 55
TABLE 21 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 58
TABLE 22 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 58
TABLE 23 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR THORACOTOMY,
BY TYPE, 2014–2021 (NO. OF PROCEDURES) 59
TABLE 24 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR THORACOTOMY,
BY REGION, 2014–2021 (USD MILLION) 60
TABLE 25 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR THORACOTOMY,
BY REGION, 2014–2021 (NO. OF PROCEDURES) 60
TABLE 26 OPEN LOBECTOMY VS. VATS: ANALYSIS OF COSTS, SURGERY TIME,
AND LENGTH OF STAY 61
TABLE 27 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR LOBECTOMY,
BY REGION, 2014–2021 (NO. OF PROCEDURES) 61
TABLE 28 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR SLEEVE RESECTION, BY REGION, 2014–2021 (NO. OF PROCEDURES) 62
TABLE 29 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR SEGMENTECTOMY,
BY REGION, 2014–2021 (NO. OF PROCEDURES) 63
TABLE 30 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR PNEUMONECTOMY,
BY REGION, 2014–2021 (NO. OF PROCEDURES) 64
TABLE 31 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2014–2021 (USD MILLION) 64
TABLE 32 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE FOR MINIMALLY INVASIVE SURGERIES, BY REGION, 2014–2021 (NO. OF PROCEDURES) 65
TABLE 33 LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 68
TABLE 34 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 68
TABLE 35 LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY REGION,
2014–2021 (NO. OF PROCEDURES) 69
TABLE 36 LIST OF RELATED CONFERENCES IN NORTH AMERICA 70
TABLE 37 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 72
TABLE 38 NORTH AMERICA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 73
TABLE 39 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 74
TABLE 40 NORTH AMERICA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES) 74
TABLE 41 NORTH AMERICA: THORACOTOMY MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 74
TABLE 42 U.S.: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 76
TABLE 43 U.S.: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 76
TABLE 44 U.S.: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 76
TABLE 45 U.S.: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES) 77
TABLE 46 CANADA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 78
TABLE 47 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 79
TABLE 48 CANADA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 79
TABLE 49 CANADA: THORACOTOMY MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 79
TABLE 50 EUROPE: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 81
TABLE 51 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 81
TABLE 52 EUROPE: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 81
TABLE 53 EUROPE: THORACOTOMY MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 82
TABLE 54 ASIA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 84
TABLE 55 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY,
2014–2021 (NO. OF PROCEDURES) 85
TABLE 56 ASIA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 86
TABLE 57 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 86
TABLE 58 ASIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 86
TABLE 59 ASIA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES) 87
TABLE 60 CHINA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 89
TABLE 61 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 89
TABLE 62 CHINA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 89
TABLE 63 CHINA: THORACOTOMY MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 90
TABLE 64 JAPAN: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 91
TABLE 65 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 92
TABLE 66 JAPAN: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 92
TABLE 67 JAPAN: THORACOTOMY MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 92
TABLE 68 INDIA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 94
TABLE 69 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 94
TABLE 70 INDIA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 94
TABLE 71 INDIA: THORACOTOMY MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 95
TABLE 72 ROA: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 96
TABLE 73 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 97
TABLE 74 ROA: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 97
TABLE 75 ROA: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES) 97
TABLE 76 ROW: LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 99
TABLE 77 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 99
TABLE 78 ROW: LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2014–2021 (NO. OF PROCEDURES) 99
TABLE 79 ROW: THORACOTOMY MARKET SIZE, BY TYPE, 2014–2021 (NO. OF PROCEDURES) 100
TABLE 80 GROWTH STRATEGY MATRIX, 2014–2016 103
TABLE 81 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014–2016 104
TABLE 82 PRODUCT LAUNCHES, 2014–2016 105
TABLE 83 EXPANSIONS, 2014–2016 106
TABLE 84 ACQUISITIONS, 2014–2016 106
TABLE 85 OTHER DEVELOPMENTS, 2014–2016 107


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 17
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 19
FIGURE 3 LUNG CANCER SURGERY MARKET: BOTTOM-UP APPROACH 21
FIGURE 4 LUNG CANCER SURGERY MARKET: TOP-DOWN APPROACH 22
FIGURE 5 DATA TRIANGULATION METHODOLOGY 23
FIGURE 6 GLOBAL LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2016 VS. 2021 (USD MILLION) 26
FIGURE 7 GLOBAL LUNG CANCER SURGICAL PROCEDURES MARKET SIZE, BY TYPE,
2016 VS. 2021 (NO. OF PROCEDURES) 27
FIGURE 8 GLOBAL LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY TYPE,
2016 VS. 2021 (USD MILLION) 28
FIGURE 9 GLOBAL LUNG CANCER SURGICAL DEVICES MARKET SIZE, BY REGION 29
FIGURE 10 GLOBAL LUNG CANCER SURGICAL DEVICES MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD 30
FIGURE 11 SURGICAL INSTRUMENTS SEGMENT TO DOMINATE THE GLOBAL LUNG CANCER SURGICAL DEVICES MARKET IN 2016 31
FIGURE 12 THORACOTOMY SEGMENT TO DOMINATE THE GLOBAL LUNG CANCER SURGICAL PROCEDURES MARKET IN 2016 32
FIGURE 13 ASIAN MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 33
FIGURE 14 LUNG CANCER SURGERY MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 35
FIGURE 15 LUNG CANCER SURGICAL DEVICES MARKET SEGMENTATION, BY TYPE 41
FIGURE 16 SURGICAL INSTRUMENTS WILL CONTINUE TO DOMINATE THE LUNG CANCER SURGICAL DEVICES MARKET DURING THE FORECAST PERIOD 42
FIGURE 17 THE THORACOTOMY SEGMENT WILL CONTINUE TO DOMINATE THE LUNG CANCER SURGICAL PROCEDURES MARKET DURING THE FORECAST PERIOD 57
FIGURE 18 THE LOBECTOMY SEGMENT WILL CONTINUE TO DOMINATE THE LUNG CANCER SURGICAL PROCEDURES MARKET FOR THORACOTOMY DURING THE FORECAST PERIOD 59
FIGURE 19 LUNG CANCER SURGICAL DEVICES MARKET,
BY REGION (MARKET SIZE AND GROWTH RATE), 2016–2021 67
FIGURE 20 LUNG CANCER SURGICAL PROCEDURES MARKET, BY REGION (NO. OF PROCEDURES AND GROWTH RATE), 2016 VS 2021 69
FIGURE 21 NORTH AMERICA: LUNG CANCER SURGERY MARKET SNAPSHOT 71
FIGURE 22 U.S. TO DOMINATE THE NORTH AMERICAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016 72
FIGURE 23 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE NORTH AMERICAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016 73
FIGURE 24 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE U.S. LUNG CANCER SURGICAL DEVICES MARKET IN 2016 75
FIGURE 25 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE CANADIAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016 78
FIGURE 26 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE EUROPEAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016 80
FIGURE 27 ASIA: LUNG CANCER SURGERY MARKET SNAPSHOT 83
FIGURE 28 CHINA ESTIMATED TO DOMINATE THE ASIAN MARKET IN 2016 84
FIGURE 29 SURGICAL INSTRUMENTS, THE LARGEST SEGMENT IN THE ASIAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016 85
FIGURE 30 LOBECTOMY SURGERIES ACCOUNT FOR THE LARGEST SHARE IN THE ASIAN THORACOTOMY MARKET IN 2016 87
FIGURE 31 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF THE CHINESE LUNG CANCER SURGICAL DEVICES MARKET IN 2016 88
FIGURE 32 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF
THE JAPANESE MARKET IN 2016 91
FIGURE 33 SURGICAL INSTRUMENTS TO DOMINATE THE INDIAN LUNG CANCER SURGICAL DEVICES MARKET IN 2016 93
FIGURE 34 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF THE ROA MARKET IN 2016 96
FIGURE 35 SURGICAL INSTRUMENTS TO HOLD A MAJOR SHARE OF THE ROW LUNG CANCER SURGICAL DEVICES MARKET IN 2016 98
FIGURE 36 KEY DEVELOPMENTS WITNESSED IN THE LUNG CANCER SURGERY MARKET, 2014–2016 101
FIGURE 37 LUNG CANCER SURGERY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015 102
FIGURE 38 GEOGRAPHIC REVENUE MIX OF THE TOP SIX MARKET PLAYERS 108
FIGURE 39 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2015) 109
FIGURE 40 ANGIODYNAMICS INC.: COMPANY SNAPSHOT (2015) 112
FIGURE 41 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2015) 114
FIGURE 42 INTUITIVE SURGICAL INC.: COMPANY SNAPSHOT (2015) 116
FIGURE 43 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2015) 118
FIGURE 44 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2015) 120


★調査レポート[肺癌手術の世界市場予測(~2021):処方術別(胸腔切開術(肺摘除術、肺切除術、セグメンテーション切除術)、最小侵襲性)、機器別(外科手術(クランプ、鉗子、リトラクタ、ステープラ)、監視方法別(カメラ、トロカール)、内視鏡装置)] ( Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021 / MAM-MD-4960) 販売に関する免責事項
[肺癌手術の世界市場予測(~2021):処方術別(胸腔切開術(肺摘除術、肺切除術、セグメンテーション切除術)、最小侵襲性)、機器別(外科手術(クランプ、鉗子、リトラクタ、ステープラ)、監視方法別(カメラ、トロカール)、内視鏡装置)] ( Lung Cancer Surgery Market by Procedure (Thoracotomy (Lobectomy, Pneumonectomy, Segmentectomy), Minimally Invasive), Device (Surgical (Clamps, Forceps, Retractors, Stapler), Monitoring (Camera, Trocar), Endoscopic Instrument) - Global Forecast to 2021 / MAM-MD-4960) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆